Targeted agents have been investigated for GC treatment, such as: HER-2, EGFR, VEGF/VEGFR, PI3K/mTOR, PARP, MMPs inhibitors and agents that could induce tumor cell apoptosis [31]. This evidence concerns the gene ERBB2 and neoplasm.